Treatment of Eyes With Diabetic Macular Edema That Had a Suboptimal Response to Antivascular Endothelial Growth Factor Therapy: 2-mg Intravitreal Triamcinolone Acetonide vs 0.7-mg Dexamethasone Implant.

Kuley, Brandon; Storey, Philip P; Pancholy, Maitri; Wibbelsman, Turner D; Obeid, Anthony; Regillo, Carl; Garg, Sunir

Kuley, Brandon; Storey, Philip P; Pancholy, Maitri; Wibbelsman, Turner D; Obeid, Anthony; Regillo, Carl; Garg, Sunir.

Afiliação

Kuley B; Mid Atlantic Retina, The Retina Service of Wills Eye Hospital, Philadelphia, PA, USA.
Storey PP; Mid Atlantic Retina, The Retina Service of Wills Eye Hospital, Philadelphia, PA, USA.
Pancholy M; Austin Retina Associates, Austin, TX, USA.
Wibbelsman TD; Mid Atlantic Retina, The Retina Service of Wills Eye Hospital, Philadelphia, PA, USA.
Obeid A; Mid Atlantic Retina, The Retina Service of Wills Eye Hospital, Philadelphia, PA, USA.
Regillo C; Mid Atlantic Retina, The Retina Service of Wills Eye Hospital, Philadelphia, PA, USA.
Garg S; Mid Atlantic Retina, The Retina Service of Wills Eye Hospital, Philadelphia, PA, USA.

J Vitreoretin Dis ; 4(5): 372-376, 2020.

Article em En | MEDLINE | ID: mdl-37008292

Palavras-chave

dexamethasone; diabetic macular edema; intravitreal steroids; triamcinolone

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Vitreoretin Dis Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google